BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38542391)

  • 21. Mesenchymal Stem Cells Obtained from Synovial Fluid Mesenchymal Stem Cell-Derived Induced Pluripotent Stem Cells on a Matrigel Coating Exhibited Enhanced Proliferation and Differentiation Potential.
    Zheng YL; Sun YP; Zhang H; Liu WJ; Jiang R; Li WY; Zheng YH; Zhang ZG
    PLoS One; 2015; 10(12):e0144226. PubMed ID: 26649753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimum criteria for defining induced mesenchymal stem cells.
    Choudhery MS; Mahmood R; Harris DT; Ahmad FJ
    Cell Biol Int; 2022 Jun; 46(6):986-989. PubMed ID: 35293653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
    Zhong S; He X; Li Y; Lou X
    Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell differentiation and matrix organization are differentially affected during bone formation in osteogenesis imperfecta zebrafish models with different genetic defects impacting collagen type I structure.
    Daponte V; Tonelli F; Masiero C; Syx D; Exbrayat-Héritier C; Biggiogera M; Willaert A; Rossi A; Coucke PJ; Ruggiero F; Forlino A
    Matrix Biol; 2023 Aug; 121():105-126. PubMed ID: 37336269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of Osteogenesis by CRISPR/Cas9 Genome Editing of the Mutated
    Jung H; Rim YA; Park N; Nam Y; Ju JH
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration.
    Tang M; Chen W; Liu J; Weir MD; Cheng L; Xu HH
    Tissue Eng Part A; 2014 Apr; 20(7-8):1295-305. PubMed ID: 24279868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice.
    Hu GW; Li Q; Niu X; Hu B; Liu J; Zhou SM; Guo SC; Lang HL; Zhang CQ; Wang Y; Deng ZF
    Stem Cell Res Ther; 2015 Apr; 6(1):10. PubMed ID: 26268554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Generation of skin-derived iPSCs from an Osteogenesis imperfecta patient carrying WNT1
    Du S; Guan X; Zhang M; Zhao X; Huang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan; 41(1):38-41. PubMed ID: 38171557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity.
    Kang R; Zhou Y; Tan S; Zhou G; Aagaard L; Xie L; Bünger C; Bolund L; Luo Y
    Stem Cell Res Ther; 2015 Aug; 6(1):144. PubMed ID: 26282538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus.
    Tongkobpetch S; Rungsiwiwut R; Pruksananonda K; Suphapeetiporn K; Shotelersuk V
    Stem Cell Res; 2019 Aug; 39():101493. PubMed ID: 31326747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endochondral Bone Tissue Engineering Using Human Induced Pluripotent Stem Cells.
    Arakura M; Lee SY; Fukui T; Oe K; Takahara S; Matsumoto T; Hayashi S; Matsushita T; Kuroda R; Niikura T
    Tissue Eng Part A; 2022 Feb; 28(3-4):184-195. PubMed ID: 34309415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-tailored application for Duchene muscular dystrophy on mdx mice based induced mesenchymal stem cells.
    Jeong J; Shin K; Lee SB; Lee DR; Kwon H
    Exp Mol Pathol; 2014 Oct; 97(2):253-8. PubMed ID: 25102299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of TRIC-B from type XIV Osteogenesis Imperfecta osteoblasts alters cell adhesion and mitochondrial function - A multi-omics study.
    Jovanovic M; Mitra A; Besio R; Contento BM; Wong KW; Derkyi A; To M; Forlino A; Dale RK; Marini JC
    Matrix Biol; 2023 Aug; 121():127-148. PubMed ID: 37348683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reiterative infusions of MSCs improve pediatric osteogenesis imperfecta eliciting a pro-osteogenic paracrine response: TERCELOI clinical trial.
    Infante A; Gener B; Vázquez M; Olivares N; Arrieta A; Grau G; Llano I; Madero L; Bueno AM; Sagastizabal B; Gerovska D; Araúzo-Bravo MJ; Astigarraga I; Rodríguez CI
    Clin Transl Med; 2021 Jan; 11(1):e265. PubMed ID: 33463067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic barcoding reveals clonal dominance in iPSC-derived mesenchymal stromal cells.
    Hollmann J; Brecht J; Goetzke R; Franzen J; Selich A; Schmidt M; Eipel M; Ostrowska A; Hapala J; Fernandez-Rebollo E; Müller-Newen G; Rothe M; Eggermann T; Zenke M; Wagner W
    Stem Cell Res Ther; 2020 Mar; 11(1):105. PubMed ID: 32138773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient induction of pluripotent stem cells differentiated into mesenchymal stem cell lineages.
    Tseng HC; Hsu TF; Lin YY; Lai WY; Liu YH; Yang YP; Chen CF; Wang CY
    J Chin Med Assoc; 2024 Mar; 87(3):267-272. PubMed ID: 38277620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. iPSC-Derived Hereditary Breast Cancer Model Reveals the
    Portier L; Desterke C; Chaker D; Oudrhiri N; Asgarova A; Dkhissi F; Turhan AG; Bennaceur-Griscelli A; Griscelli F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9 correction of a dominant cis-double-variant in COL1A1 isolated from a patient with osteogenesis imperfecta increases the osteogenic capacity of induced pluripotent stem cells.
    Cao Y; Li L; Ren X; Mao B; Yang Y; Mi H; Guan Y; Li S; Zhou S; Guan X; Yang T; Zhao X
    J Bone Miner Res; 2023 May; 38(5):719-732. PubMed ID: 36734182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation of a patient-specific induced pluripotent stem cell line, KSCBi006-A, for osteogenesis imperfecta type I with the COL1A1, c.3162delT mutation.
    Kim BY; Ko JM; Park MH; Koo SK
    Stem Cell Res; 2019 Dec; 41():101622. PubMed ID: 31715426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modification of COL1A1 in Autologous Adipose Tissue-Derived Progenitor Cells Rescues the Bone Phenotype in a Mouse Model of Osteogenesis Imperfecta.
    Liu Y; Wang Z; Ju M; Zhao Y; Jing Y; Li J; Shao C; Fu T; Lv Z; Li G
    J Bone Miner Res; 2021 Aug; 36(8):1521-1534. PubMed ID: 33950576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.